Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Raymond James analyst Buck Horne upgraded the rating for Weyerhaeuser Company (NYSE:WY) from Market Perform to Outperform and announced a $32 price target. Weyerhaeuser shares closed at $27.50 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju upgraded the rating for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) from Neutral to Buy and maintained the price target of $20. Aclaris Therapeutics shares closed at $2.72 on Friday. See how other analysts view this stock.
- Piper Sandler analyst Crispin Love upgraded GCM Grosvenor Inc. (NASDAQ:GCMG) from Neutral to Overweight and raised the price target from $12.5 to $14. GCM Grosvenor shares closed at $11.75 on Friday. See how other analysts view this stock.
- Raymond James analyst Buck Horne upgraded the rating for PotlatchDeltic Corporation (NASDAQ:PCH) from Market Perform to Outperform and announced a $45 price target. PotlatchDeltic shares closed at $38.75 on Friday. See how other analysts view this stock.
Considering buying WY stock? Here's what analysts think:
Read This Next:
- Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock